Brand Institute, PSC Biotech, and the Biotechnology Innovation Organization (BIO) have partnered to provide a Webinar Series on “The Art and Science of Naming Drugs and Medical Devices”. The Two-Part Series will focus on technical and strategic considerations and the legal and regulatory challenges of medical product name development.
Join us on Wednesday, January 27, 2021 at 12:00 PM CST to hear about “The Science Behind Nonproprietary (Generic) Drug Naming” with world-renowned nonproprietary naming expert and the President of Drug Safety Institute’s Nonproprietary Naming Division, Sophia Fuerst. Learn about the taxonomy of nonproprietary nomenclature, the differences between generic and brand naming, and the regulatory agencies/processes involved.
President, Nonproprietary Names Division
Ms. Fuerst joined Drug Safety Institute’s Nonproprietary (USAN/INN) Names Division as Managing Director in 2005, and was promoted to President in 2007. Ms. Fuerst was formerly Director of the USAN Program at the American Medical Association (AMA) and served in various positions during her 18-year tenure with the Program, including AMA senior staff scientist in the area of Drug Nomenclature. The AMA USAN Program is responsible for evaluating and approving nonproprietary names. Ms. Fuerst holds a B.S. in Biology/Chemistry (pre-med) from St. Joseph’s College, an M.S. in Medicinal Chemistry from the University of Chicago and an M.B.A. from Governor’s State University in Illinois.